Organovo Holdings plans to conduct $33 million at-the-market agreement

Cantor Fitzgerald will sell shares through offering for 3% commission

By Devika Patel

Knoxville, Tenn., Dec. 31 – Organovo Holdings, Inc. negotiated a $33 million at-the-market program with Cantor Fitzgerald & Co. on Dec. 30, according to an 8-K filed Wednesday with the Securities and Exchange Commission.

Cantor will be paid a 3% commission.

Based in San Diego, Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.